Get a demo
Log In
EDGE Insights

EDGE Insights

This week:
Last week:

Print your heart out: Bioprinting and the future of organs

Imagine instant medical transplants or implants with zero risk of rejection and no dangerous anti-rejection medicines. That is the future that bioprinting promises. 
In June 2022, the first human trial of a bioprinted organ was conducted in the US—a bioprinted human ear implant was used to treat a patient with a congenital condition. To reduce the risk of rejection, the implant was printed using patient-specific tissue, with the design based on the patient’s opposite ear. This marked a significant step forward in the regulatory acceptance and commercial viability of bioprinting as a solution to the current shortage of organ donors.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.